{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:32:01Z","timestamp":1784129521250,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2025.126743","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T19:56:21Z","timestamp":1737748581000},"page":"126743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prevalence of chronic hepatitis B virus infection among children in Uzbekistan: Impact of vaccination"],"prefix":"10.1016","volume":"48","author":[{"given":"Nino","family":"Khetsuriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilorom","family":"Tursunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rano","family":"Kasimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidkhon","family":"Sharapov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansurbek","family":"Matyakubov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renat","family":"Latipov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila","family":"Mosina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakhodir","family":"Yusupaliyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkin","family":"Musabaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126743_bb0005","series-title":"Global hepatitis report 2024: Action for access in low- and middle-income countries","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.vaccine.2025.126743_bb0010","author":"Uzbekistan State Statistics Agency"},{"issue":"30","key":"10.1016\/j.vaccine.2025.126743_bb0015","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"9","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126743_bb0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.126743_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2025.126743_bb0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/S0950268813000940","article-title":"Prevalence and estimation of hepatitis B and C infections in the WHO European region: a review of data focusing on the countries outside the European Union and the European free trade association","volume":"142","author":"Hope","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2025.126743_bb0035","first-page":"234","article-title":"The disease burden of hepatitis B in Uzbekistan","volume":"40","author":"Beutels","year":"2000","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2025.126743_bb0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2025.126743_bb0045","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2025.126743_bb0050","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126743_bb0055","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126743_bb0060","author":"World Health Organization Immunization Portal"},{"key":"10.1016\/j.vaccine.2025.126743_bb0065","series-title":"UNICEF, United Nations Population Fund. Uzbekistan \u2013 Monitoring the status of children and women: Multiple Indicator Cluster Survey (MICS)","author":"The State Statistical Committee of the Republic of Uzbekistan","year":"2006"},{"key":"10.1016\/j.vaccine.2025.126743_bb0070","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","article-title":"The global impact of vaccination against hepatitis B: a historical overview","volume":"26","author":"Zanetti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126743_bb0075","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1016\/j.vaccine.2015.05.092","article-title":"Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan","volume":"33","author":"Khetsuriani","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126743_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.vaccine.2013.11.004","article-title":"A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination","volume":"32","author":"Nguyen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126743_bb0085","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1016\/j.vaccine.2013.05.009","article-title":"Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia","volume":"31","author":"Mao","year":"2013","journal-title":"Vaccine"},{"issue":"31 Suppl 9","key":"10.1016\/j.vaccine.2025.126743_bb0090","doi-asserted-by":"crossref","first-page":"J66","DOI":"10.1016\/j.vaccine.2013.03.043","article-title":"The impact of hepatitis B vaccine in China and in the China GAVI project","volume":"27","author":"Hadler","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126743_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-14-7","article-title":"Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia hepatitis intervention study (1986-90) and in the nationwide immunisation program","volume":"14","author":"Peto","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126743_bb0100","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126743_bb0110","series-title":"World Health Organization Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030","year":"2022"},{"key":"10.1016\/j.vaccine.2025.126743_bb0120","first-page":"1030","article-title":"Progress toward hepatitis B control \u2014 World Health Organization European region, 2016\u20132019","volume":"70","author":"Khetsuriani","year":"2021","journal-title":"MMWR Weekly"},{"key":"10.1016\/j.vaccine.2025.126743_bb0125","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126743_bb0130","author":"World Health Organization Regional Office for Europe (WHO\/Europe)"},{"key":"10.1016\/j.vaccine.2025.126743_bb0140","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126743_bb0145","author":"UNICEF. A state of the world'\u2019s children"},{"key":"10.1016\/j.vaccine.2025.126743_bb0150","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126743_bb0155","series-title":"WHO Public Report August 2020, version 4.0. WHO Prequalification of In Vitro Diagnostics. Public Report. Product: Bioline HBsAg WB (WHO reference number: PQDx 0219\u2013012-00)","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.vaccine.2025.126743_bb0160","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.vaccine.2021.02.042","article-title":"Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018","volume":"39","author":"Minta","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126743_bb0165","first-page":"1","article-title":"Evaluation of Four Rapid Tests for Detection of Hepatitis B Surface Antigen in Ivory Coast","author":"Dembele","year":"2020","journal-title":"J Immunol Res 2020"},{"key":"10.1016\/j.vaccine.2025.126743_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2021.115452","article-title":"In-field Evaluation of SD Bioline HBsAg Whole Blood Rapid Test in Pregnant Women in Cambodia: the ANRS 12345 TA PROHM Study","volume":"101","author":"Segeral","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126743_bb0175","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1423-0410.2009.01272.x","article-title":"Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes","volume":"98","author":"Scheiblauer","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.vaccine.2025.126743_bb0185","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126743_bb0190","doi-asserted-by":"crossref","first-page":"958","DOI":"10.15585\/mmwr.mm7130a2","article-title":"Progress toward the elimination of mother-to-child transmission of hepatitis B\u2014worldwide, 2016\u20132021","volume":"71","author":"Khetsuriani","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.126743_bb0195","article-title":"Interim guidance for country validation of viral hepatitis elimination","author":"World Health Organization","year":"2021","journal-title":"WHO"},{"key":"10.1016\/j.vaccine.2025.126743_bb0200","article-title":"Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy","author":"World Health Organization","year":"2020","journal-title":"WHO"},{"key":"10.1016\/j.vaccine.2025.126743_bb0205","series-title":"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection","author":"World Health Organization","year":"2024"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126743_bb0210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000050066","article-title":"Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in Uzbekistan","volume":"44","author":"Ruzibakiev","year":"2001","journal-title":"Intervirology"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126743_bb0215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"18","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126743_bb0220","first-page":"39","article-title":"Results of the examination of patients with viral hepatitis for HBsAg in Kashka-Darya Province, Uzbek SSR [Article in Russian]","author":"Kurbanov","year":"1986","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126743_bb4220","first-page":"304","article-title":"Patterns in perinatal infection with the hepatitis B virus in areas contrasted by the level of HBsAg and HBeAg carriage","volume":"35","author":"Kuzin","year":"1990","journal-title":"Vopr Virusol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126743_bb0225","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/liv.15514","article-title":"Viral hepatitis elimination challenges in low- and middle income countries-Uzbekistan hepatitis elimination program (UHEP)","volume":"43","author":"Musabaev","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.vaccine.2025.126743_bb0230","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.15585\/mmwr.mm6934a3","article-title":"Progress toward hepatitis B and hepatitis C elimination using a catalytic funding model - Tashkent, Uzbekistan, December 6, 2019-march 15, 2020","volume":"69","author":"Dunn","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T18:04:34Z","timestamp":1743876274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"alternative-id":["S0264410X25000404"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126743","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of chronic hepatitis B virus infection among children in Uzbekistan: Impact of vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126743"}}